| Document |
Document Title |
|
WO/1994/007868A1 |
Novel naphthol derivatives represented by formula (I), wherein each of R1 and R2, which may be the same or different, represents hydrogen, alkyl, cycloalkyl, or phenyl optionally substituted with at least one member selected from alkyl, ...
|
|
WO/1994/005643A1 |
This invention relates to novel neopentyl difluoroamino compounds which are useful as plasticizers and oxidizers in energetic formulations, such as propellants, explosives, and gasifiers. These neopentyl difluoroamino compounds can be pr...
|
|
WO/1993/025588A1 |
The invention concerns dispersions or solutions of a polymerizate, polycondensate or polyadduct formed by a radical reaction and including 0.001 to 20 % by wt. of aldehyde-CHO or ketone-CO-groups, the dispersion or solution containing as...
|
|
WO/1993/017994A1 |
Novel substituted cis-1,2-dihydroxy-cyclohexadiene compounds, useful as intermediates in the production of compounds for use as intermediates in the production of agrochemicals and pharmaceuticals, and a microbial process for the prepara...
|
|
WO/1993/018023A1 |
Compounds of formula (I), and salts and prodrugs thereof, wherein Q1 is halo substituted phenyl; naphthyl; indolyl; benzthiophenyl; benzofuranyl; benzyl; or fluorenyl; .... is an optional covalent bond; one of X and Y is H and the other ...
|
|
WO/1993/016124A1 |
The invention concerns diaminocarbonate compounds which are suitable in particular for use as low-odour catalysts in the production of solid or cellular urethane and/or urea polymers. Such compounds may prepared by reacting aminoalcohols...
|
|
WO/1993/016061A1 |
Mixtures of optically active cyclohexenone oxime ethers, with an R and S configuration in the oxime ether section of formula (I) where R?1¿ = C¿1?-C¿6? alkyl; Z = (a), (b), (c), (d), (e); X = C¿1?-C¿4? alkyl, C¿1?-C¿4? halogen alk...
|
|
WO/1993/016062A1 |
Mixtures of optically active cyclohexenone oxime ethers, with an R and S configuration in the oxime ether section of formula (I) where R?1¿ = C¿1?-C¿6? alkyl; X = NO¿2?, CN, halogen, C¿1?-C¿4? alkyl, C¿1?-C¿4? halogen alkyl; n = ...
|
|
WO/1993/015046A1 |
Carbamate having the formula (I), its plant-compatible acid addition and basic addition products, and fungicides containing the same are disclosed.
|
|
WO/1993/013052A1 |
The present invention is concerned with antiretroviral (e.g. anti HIV-1) compounds having formula (I-a) or (I-b). Pharmaceutical compositions containing said compounds of formula (I-a) or (I-b), and processes of preparing said compounds ...
|
|
WO/1993/012777A1 |
Methods for regulating cation transport across cellular membranes possessing cation channels are provided. The cell membrane possessing a specific ion channel is exposed to a non-aromatic polyamine compound having a lysine- or arginine-b...
|
|
WO/1993/007118A1 |
The invention concerns 9-substituted bicylo[3.3.0]octane derivaties of formula (I) and their physiologically acceptable bases, and also the $g(a)-, $g(b)- or $g(g)-cyclodextrin clathrates, and the compounds of formula (I) encapsulated in...
|
|
WO/1992/021648A1 |
The present invention relates to compounds of formula (I).
|
|
WO/1992/017176A1 |
Compounds are disclosed which are retroviral protease inhibitors. Also disclosed are methods of using the compounds and compositions for inhibiting a retroviral protease and for treating an HIV infection.
|
|
WO/1992/015546A1 |
Compounds and a method useful for protection of tissue cells in a mammalian body from irreversible damages due to lactic acidosis caused by oxygen deficiency. The protection is achieved by administering a compound having a cell membrane ...
|
|
WO/1992/015555A2 |
Fluorinated alkene compounds useful for and methods of controlling nematodes, insects, and acarids that prey on agricultural crops. Polar compounds, for example, 3,4,4-trifluoro-3-butene-1-amine or 3,4,4-trifluoro-3-butenoic acid, are pa...
|
|
WO/1992/007860A2 |
The present invention relates to novel technetium-99m complexes and to methods of preparing the complexes. The present invention further relates to a radiopharmaceutical composition comprising the complexes, to the use of the composition...
|
|
WO/1992/002495A1 |
The invention relates to cyclopentane derivatives of formula (I) and their salts with physiologically tolerables bases and the $g(a), $g(b) or $g(g)-cyclodextrin clathrates and the liposome-encapsulated compounds of formula (I), a proces...
|
|
WO/1992/002494A1 |
The invention relates to cyclopentane derivatives of formula (I) in which there is a double bond between the carbon atoms of centres a-b or b-c, and their salts with physiologically tolerable bases, and $g(a), $g(b) or $g(g)-cyclodextrin...
|
|
WO/1992/001682A1 |
Compounds of the structure (I) where p and q are zero or one, but cannot both be the same, M is a pharmaceutically acceptable cation or a metabolically cleavable group, B is a valence bond or a straight or branched alkylene group, R is a...
|
|
WO/1991/019725A2 |
Heterocyclic anthracyclinone and anthracycline derivatives are described, which are useful in the treatment of cancer and tumors, such as breast cancer, leukemia, lung cancer, colon cancer, ovarian cancer, renal cancer, CNS cancer and me...
|
|
WO/1991/017138A1 |
A process for preparing 3,4-difluoroaniline comprising reacting 1-hydroxylamine-3-fluorobenzene with anhydrous hydrogen fluoride in the absence of oxygen. This compound is useful as a starting material for preparation of quinolone antiba...
|
|
WO/1991/001297A1 |
The invention relates to new 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes, a process for preparing them and their use as drugs.
|
|
WO/1991/000853A1 |
Polyamine compounds are used as agents regulating ionic conductances in cellular membranes. These polyamines are used in blocking, modulating or activating calcium and other cationic channels in neuronal cell membranes and in blocking, m...
|
|
WO/1990/008788A1 |
This invention relates to an N,N-dialkylaminoalkyl(meth)acrylamide composition of general formula (II), wherein R3 represents a hydrogen atom or a methyl group, R4 and R5 represent each an alkyl group having one to four carbon atoms, and...
|
|
WO/1990/001024A1 |
Novel magnetic resonance imaging agents comprise complexes of paramagnetic ions with alkoxyalkylamide derivatives of diethylenetriaminepentaacetic acid (''DTPA'') or ethylenediaminetetyraacetic acid (''EDTA''). These novel imaging agents...
|
|
WO/1988/010250A1 |
A process for the production of a carbamate having formula (I), wherein X and Y are independently either hydrogen, a hydrocarbyl group or a hetero-substituted hydrocarbyl group or the group of formula (II), wherein Z is either a divalent...
|
|
WO/1988/007855A1 |
Pharmaceutical compositions suitable for administration by inhalation and containing pentamidine, or pharmaceutically acceptable salt thereof, in powder form. Such compositions include pressurised aerosol compositions and non-pressurised...
|
|
WO/1988/007036A1 |
Compound having beta-adrenergic blocking properties having formula (I), wherein X is -O-, -CH2- or -----; Y is =O or a derivatized keto group, each of which is hydrolyzable or enzymatically convertible to a ketonic group; R is alkyl havi...
|
|
WO/1988/005050A1 |
A renin inhibiting compound of formula (I), wherein A is a substituent; W is C=O or CHOH; U is CH2 or NR2, provided that when W is CHOH then U is CH2; R1 is loweralkyl, cycloalkylmethyl, benzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl-m...
|
|
WO/1988/004291A1 |
Organo N-hydroxyimidates are prepared by reacting an organonitrile with an organic alcohol and with a hydrogen halide, in the presence of an organic solvent (which may include an excess of the organonitrile reactant), under anhydrous con...
|
|
WO/1988/003925A1 |
A water-soluble square-planar cis-platinum(II) four-coordinate complex having the formula: trans-R,R-DACH Pt(II) X2 or trans-R,R-DACH Pt(II) Y, wherein X is a monovalent cation, two of which are present, selected from the group consistin...
|
|
WO/1988/000181A1 |
Antiviral organic guanidine derivatives compositions; a process of producing the antiviral compositions; and a method for inhibiting viruses utilizing the compositions. More particularly, the compositions are tubastrines derived from mar...
|
|
WO/1987/007312A1 |
Process for producing diaminoalkane derivatives of general formula (I) where R1 is an acyl residue or sulfonyl residue, R2 represents an alkyl group with up to 6 carbon atoms and possibly substituted by a hydroxy group, a lower alkanoyl ...
|
|
WO/1987/006929A1 |
A new chiral reagent of formula (I), wherein X is halogen, an azide group or a succinimidyl group and wherein R is an alkyl group or a trifluormethyl group. The invention further relates to a method for derivatization, determination and ...
|
|
WO/1987/006575A1 |
A composite comprising a substrate and an elastomeric coating adhered to at least one surface of said substrate, said elastomeric coating having a thickness of about 1 to about 100 micrometers, wherein said elastomeric coating comprises ...
|
|
WO/1987/005898A2 |
Method for retarding plant growth by applying to the plant an effective amount of a malonic acid derivative compound. This invention also relates to novel malonic acid derivative compounds and processes for the preparation thereof.
|
|
WO/1987/005618A1 |
r-1-Cyan-1-R2-cis-4-R1 cyclohexane compounds, where R is CH2X, amino, amidino, formyl, p-R3-phenyl or 4-R3-biphenyl-4'-yl, where X is hydroxy, halogen or a sulphonate group and R3 is amino, amidino, formyl, hydroxy, carboxy, alkanoyl wit...
|
|
WO/1987/005603A1 |
A compound having formula (I), wherein R1 is the esterification residue of an alcohol (R1-OH) having from 1 to 8 carbon atoms; R2 is a substituted or unsubstituted aryl, cycloalkyl or alkyl group having from 1 to 8 carbon atoms; R3 is H ...
|
|
WO/1987/005014A1 |
Compounds represented by general formula (I), (wherein Y-Z represents (II), -CH=CH- or -CH2CH2-, R1 and R2 each represents a substituent, R3 represents hydrogen, alkyl or alkoxy, R4 represents hydrogen, alkyl, optionally substituted alke...
|
|
WO/1987/004349A1 |
A genus of novel peptide analogs which have potent renin-inhibiting activity, methods of treating renin-based hypertension using these compounds, and pharmaceutical compositions containing these compounds as active ingredients.
|
|
WO/1987/004348A1 |
Acylated cyanamide compounds useful for ethanol deterrence of the formula RCONHCN, wherein R is a lipophilic acyl group or is derived from an (N-substituted)-alphaaminoacyl group.
|
|
WO/1987/004152A1 |
Compounds of formula (I) where k is 0 or 1; one of m and n is 0 and the other is 1; Ar represents a phenyl or a naphthyl group, both of which optionally may be substituted by one or more substituents selected from C1-4 alkyl (which may i...
|
|
WO/1987/003584A1 |
A process for preparing a racemic or chiral aryloxypropanolamine (1) or arylethanolamine (2) of formula (1) or (2), wherein Ar is aryl, substituted aryl, heteroaryl, or aralkyl and R is alkyl, substituted alkyl, aralkyl, or WB wherein W ...
|
|
WO/1987/003583A1 |
A process for preparing a racemic or chiral aryloxypropanolamine (1) or arylethanolamine (2) of the formula (1) or (2) wherein Ar is aryl, substituted aryl, heteroaryl, or aralkyl and R is alkyl, substituted alkyl, aralkyl or WB wherein ...
|
|
WO/1987/003281A1 |
A derivative of 2-methylenepropane-1,3-diol of general formula (I), where O-A1 and O-A2, which can be the same or different, each represents O, O-C(O), O-C(O)NH, O-C(S)NH or O-C(O)O, R1 represents an alkyl or alkenyl group of 10 - 22 car...
|
|
WO/1987/002356A1 |
Compounds of the general formula (2). X is 0 or 6. R1, R2, R3, R4, R5 and R6 can be selected from various substituent groups and it is possible for (a) R4 and R5 and (b) R4 and R6 to form cyclic substituents together. The compounds have ...
|
|
WO/1986/007355A1 |
Compounds represented by the general formula (I), (wherein R1 represents a halogen atom or a methyl group, R2 represents a hydrogen atom or a halogen atom, R3 represents a hydrogen atom, a halogen atom or a methyl group, and X and Y each...
|
|
WO/1986/005781A1 |
Novel 1-(4-phenoxyphenyl)-3-benzoyl urea compounds are provided together with methods for their preparation and the use of said compounds as the active toxicant in pesticidal compositions.
|
|
WO/1986/005780A1 |
Novel 1-(4-phenoxyphenyl)-3-benzoyl urea compounds are provided together with methods for their preparation and the use of said compounds as the active toxicant in pesticidal compositions.
|
